Clinical Trial Update: Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of deferasirox and deferiprone for severe iron overload in thalassemia patients has completed and posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major with Severe Transfusional Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)
• Deferiprone (deferiprone)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Thalassemia Major With Severe Transfusional Iron Overload | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-06